Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone PR tablets for opioid-induced constipation
2012-003218-14Phase 3Completed
- Sponsor
- Develco Pharma
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid-induced constipation (OIC) comparing Naloxone hydrochloride prolonged-release tablets with Placebo (2 arms). Primary endpoint: Absolute change in Bowel Function Index. Started Sep 2012; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2012-003218-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003218-14.